- Research
- 2022-2026 Research Strategy
- Open Clinical Trials
- Closed Clinical Trials
- What is a Clinical Trial?
- Why Participate in a Clinical Trial
- Remote Telehealth Pre-Screening Process
- Research Achievements
- Publications
- Research Development and Funding
- Participating Institutions
- International Collaboration
- BCT Trials & Projects Summary
- Translational Research
- Clinical Fellowship Program
- International Fellowship Support
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
IBCSG 13-93
Closed
IBCSG 13-93
BCT Study Chair:
John Forbes
Adjuvant therapy for premenopausal patients with node positive breast cancer who are not suitable for endocrine therapy alone.
936
INTERNATIONAL
Total number of trial
participants internationally
358
AUSTRALIA & NEW ZEALAND
Total number of trial participants
in Australia and New Zealand
22
INSTITUTIONS
Total number of participating institutions
in Australia and New Zealand
IBCSG 13-93 PUBLICATIONS
2024
Effect of obesity in premenopausal ER+ early breast cancer: EBCTCG data on 80,000 patients in 70 trials.
Pan H, Gray R, on behalf of the EBCTCG. Journal of Clinical Oncology. 2024; 32:5s(SABCS 2024), [Abstract Number SESS-1911; GS2-09], Abstract
Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials.
Early Breast Cancer Trialists’ Collaborative Group. The Lancet. 2024; 4041407-18, epub 12 October 2024, E-pub
2013
Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93
Pagani O, Gelber S, Colleoni M, Price KN, Simoncini E Breast Cancer Research Treatment 2013; 142455-459, Journal
Prognostic significance of quality-of-life scores in early stage and relapsed breast cancer: results from seven randomized trials of the International Breast Cancer Study Group
Lee CK, Coates A, Hudson M, Ribi K, Bernhard J SABCS 2013 2013; Poster P6-08-04, Poster
2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
Karlsson P, Cole BF, Chua BH, Lindtner J, Collins JP, Kovác A, Thürlimann B, Crivellari D, Castiglione-Gertsch M, Forbes JF, Gelber RD, Goldhirsch A, Gruber G Annals of Oncology 2012; 23(11):2852-2858, E-pub
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Öhlschlegel C, Price KN, Gelber RD, Regan MM, Thürlimann B Annals of Oncology 2012; 23(11):2843-2851, E-pub
Institutions
-
NSW
-
SA
-
VIC
-
WA
-
New Zealand